Emergent Biosolutions earnings were -$176.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest EBS earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$180.2M, down 2,750% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EBS reported annual earnings of $52.6M, with -127.6% growth. The next EBS earnings date is Nov 4, 2026.
Emergent Biosolutions Earnings Reports & History FAQ
What were Emergent Biosolutions's earnings last quarter?
On EBS's earnings call on Aug 5, 2026, Emergent Biosolutions (NYSE: EBS) reported Q2 2026 earnings per share (EPS) of -$3.49, up 1,486.36% year over year. Total EBS earnings for the quarter were -$180.20 million. In the same quarter last year, Emergent Biosolutions's earnings per share (EPS) was -$0.22.
The next EBS earnings date is Nov 4, 2026. Add EBS to your watchlist to be reminded of Emergent Biosolutions's next earnings date.
Is Emergent Biosolutions profitable or losing money?
As of the last Emergent Biosolutions earnings report, Emergent Biosolutions is currently losing money. Emergent Biosolutions's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$176.80 million, a 226.74% decrease year over year.
What was EBS's earnings growth in the past year?
As of Emergent Biosolutions's earnings date in Aug 5, 2026, Emergent Biosolutions's earnings has grown year over year. EBS earnings in the past year totalled -$176.80 million.
What are Emergent Biosolutions's earnings expectations?
The current EPS estimate for Emergent Biosolutions's earnings report in Nov 4, 2026 is -$0.45.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.